1-Cyclohexyl-3-dodecyl urea
CAS No. 402939-18-8
1-Cyclohexyl-3-dodecyl urea( CDU | N-Cyclohexyl-N-dodecyl urea | NCND )
Catalog No. M21583 CAS No. 402939-18-8
1-Cyclohexyl-3-dodecyl urea is a highly selective soluble epoxide hydrolase (sEH) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 90 | In Stock |
|
| 50MG | 149 | In Stock |
|
| 100MG | 224 | In Stock |
|
| 200MG | 333 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Cyclohexyl-3-dodecyl urea
-
NoteResearch use only, not for human use.
-
Brief Description1-Cyclohexyl-3-dodecyl urea is a highly selective soluble epoxide hydrolase (sEH) inhibitor.
-
Description1-Cyclohexyl-3-dodecyl urea is a highly selective soluble epoxide hydrolase (sEH) inhibitor.
-
In Vitro——
-
In Vivo1-Cyclohexyl-3-dodecyl urea (CDU; N-Cyclohexyl-N-dodecyl urea; NCND) (?intraperitoneal injection; 3mg/day; 4 days) lowers systolic blood pressure by 30 mm Hg in Ang II hypertensive animals, whereas the corn oil vehicle has no effect on blood pressure in normotensive or Ang II hypertensive animals. Animal Model:Male Sprague-Dawley ratsDosage:3mg/day Administration:Intraperitoneal injection; 4 days Result:Had antihypertensive properties.
-
SynonymsCDU | N-Cyclohexyl-N-dodecyl urea | NCND
-
PathwayOthers
-
TargetOther Targets
-
RecptorsEH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number402939-18-8
-
Formula Weight310.52
-
Molecular FormulaC19H38N2O
-
Purity>98% (HPLC)
-
SolubilityEthanol:16.67 mg/mL (53.68 mM; Need ultrasonic)
-
SMILESCCCCCCCCCCCCNC(=O)NC1CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Imig JDet al. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.Hypertension. 2002 Feb;39(2 Pt 2):690-4.
molnova catalog
related products
-
Labetuzumab
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
-
Perillen
Perillen is an actiive constituent in the drug which promotes enterocinesia. Perillen demonstrates strong resistance activity against staphylococcus aureus and E.coli.
-
GGTI 298
GGTI 298 is a geranylgeranyltransferase I inhibitor with ability to arrest human tumor cells in the G1 phase of the cell cycle and induce apoptosis.
Cart
sales@molnova.com